首页|Epidemiological and clinical features,treatment status,and economic burden of traumatic spinal cord injury in China:a hospital-based retrospective study

Epidemiological and clinical features,treatment status,and economic burden of traumatic spinal cord injury in China:a hospital-based retrospective study

扫码查看
原文链接
  • 万方数据
  • 维普
Traumatic spinal cord injury is potentially catastrophic and can lead to permanent disability or even death.China has the largest population of patients with traumatic spinal cord injury.Previous studies of traumatic spinal cord injury in China have mostly been regional in scope;national-level studies have been rare.To the best of our knowledge,no national-level study of treatment status and economic burden has been performed.This retrospective study aimed to examine the epidemiological and clinical features,treatment status,and economic burden of traumatic spinal cord injury in China at the national level.We included 13,465 traumatic spinal cord injury patients who were injured between January 2013 and December 2018 and treated in 30 hospitals in 11 provinces/municipalities representing all geographical divisions of China.Patient epidemiological and clinical features,treatment status,and total and daily costs were recorded.Trends in the percentage of traumatic spinal cord injuries among all hospitalized patients and among patients hospitalized in the orthopedic department and cost of care were assessed by annual percentage change using the Joinpoint Regression Program.The percentage of traumatic spinal cord injuries among all hospitalized patients and among patients hospitalized in the orthopedic department did not significantly change overall(annual percentage change,-0.5%and 2.1%,respectively).A total of 10,053(74.7%)patients underwent surgery.Only 2.8%of patients who underwent surgery did so within 24 hours of injury.A total of 2005(14.9%)patients were treated with high-dose(≥500 mg)methylprednisolone sodium succinate/methylprednisolone(MPSS/MP);615(4.6%)received it within 8 hours.The total cost for acute traumatic spinal cord injury decreased over the study period(-4.7%),while daily cost did not significantly change(1.0%increase).Our findings indicate that public health initiatives should aim at improving hospitals'ability to complete early surgery within 24 hours,which is associated with improved sensorimotor recovery,increasing the awareness rate of clinical guidelines related to high-dose MPSS/MP to reduce the use of the treatment with insufficient evidence.

Chinaclinical featurescostsepidemiologymethylprednisolone sodium succinatemethylprednisoloneretrospective studytraumatic spinal cord injurytreatment

Hengxing Zhou、Yongfu Lou、Lingxiao Chen、Yi Kang、Lu Liu、Zhiwei Cai、David B.Anderson、Wei Wang、Chi Zhang、Jinghua Wang、Guangzhi Ning、Yanzheng Gao、Baorong He、Wenyuan Ding、Yisheng Wang、Wei Mei、Yueming Song、Yue Zhou、Maosheng Xia、Huan Wang、Jie Zhao、Guoyong Yin、Tao Zhang、Feng Jing、Rusen Zhu、Bin Meng、Li Duan、Zhongmin Zhang、Desheng Wu、Zhengdong Cai、Lin Huang、Zhanhai Yin、Kainan Li、Shibao Lu、Shiqing Feng

展开 >

Department of Orthopedics,The Second Hospital,Cheeloo College of Medicine,Shandong University,Shandong,China

Department of Orthopedics,Shandong University Center for Orthopedics,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Shandong,China

Department of Orthopedics,Tianjin Medical University General Hospital,International Science and Technology Cooperation Base of Spinal Cord Injury,Tianjin Key Laboratory of Spine and Spinal Cord,Tianjin,China

Faculty of Medicine and Health,The Back Pain Research Team,Sydney Musculoskeletal Health,The Kolling Institute,University of Sydney,Sydney,NSW,Australia

Department of Spine Surgery,Honghui Hospital,Xi'an Jiaotong University,Xi'an,Shaanxi Province,China

Department of Burns and Plastic Surgery,The Fourth Medical Center of Chinese PLA General Hospital,Beijing,China

Faculty of Medicine and Health,School of Health Sciences,University of Sydney,NSW,Australia

Sydney Spine Institute,Burwood,Sydney,NSW,Australia

Laboratory of Epidemiology,Tianjin Neurological Institute,Department of Neurology,Tianjin Medical University General Hospital&Tianjin Neurological Institute,Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System,Ministry of Education and Tianjin City,Tianjin,China

Department of Orthopedics,Henan Provincial People's Hospital,Zhengzhou,Henan Province,China

Department of Spinal Surgery,The Third Hospital of Hebei Medical University,Shijiazhuang,Hebei Province,China

Department of Orthopedics,The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan Province,China

Department of Spine Surgery,Zhengzhou Orthopedics Hospital,Zhengzhou,Henan Province,China

Department of Orthopedic Surgery and Orthopedic Research Institute,West China Hospital,Sichuan University,Chengdu,Sichuan Province,China

Department of Orthopedics,Xinqiao Hospital,Army Medical University,Chongqing,China

Department of Orthopedics,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning Province,China

Department of Spinal Surgery,Shengjing Hospital of China Medical University,Shenyang,Liaoning Province,China

Shanghai Key Laboratory of Orthopedic Implants,Department of Orthopedic Surgery,Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China

Department of Orthopedics,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu Province,China

Department of Spinal Surgery,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai,China

Department of Spinal Surgery,Tianjin Hospital,Tianjin,China

Department of Spine Surgery,Tianjin Union Medical Center,Tianjin,China

Department of Orthopedic Surgery,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu Province,China

Department of Orthopedics,Shenzhen Intelligent Orthopedics and Biomedical Innovation Platform,Guangdong Artificial Intelligence Biomedical Innovation Platform,Shenzhen Second People's Hospital,The First Affiliated Hospital of Shenzhen University Health Science Center,Shenzhen,Guangdong Province,China

Department of Orthopedics,The Third Affiliated Hospital of Southern Medical University,Guangzhou,Guangdong Province,China

Department of Spine Surgery,Shanghai East Hospital Affiliated to Tongji University School of Medicine,Shanghai,China

Department of Orthopedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China

Department of Orthopedics,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou,Guangdong Province,China

Department of Orthopedics,The First Affiliated Hospital,Xi'an Jiaotong University,Xi'an,Shaanxi Province,China

Department of Orthopedic Surgery,Affiliated Hospital of Chengdu University,Chengdu,Sichuan Province,China

Department of Orthopedics,Beijing Xuanwu Hospital,Capital Medical University,Beijing,China

展开 >

国家重点研发计划

2019YFA0112100

2024

10.4103/1673-5374.382257

中国神经再生研究(英文版)
中国康复医学会

中国神经再生研究(英文版)

CSTPCD
影响因子：0.902
ISSN：1673-5374
年,卷(期)：2024.19(5)
  • 52